ripekg:evaluation/RIPEA2FDF154C3D3A24A0 |
prov:used |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA2FDF154C3D3A24A0 |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA2FDF154C3D3A24A0 |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
ripe:concerns |
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
ripe:recruitmentEndDate |
22-11-2022 |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
ripe:recruitmentEndDateExtractionRationale |
Table 1: 'Study Period' for Wu et al., 2023 is 'Oct 12,22 - Nov 22, 22'. |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
ripe:recruitmentStartDate |
12-10-2022 |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
ripe:recruitmentStartDateExtractionRationale |
Table 1: 'Study Period' for Wu et al., 2023 is 'Oct 12,22 - Nov 22, 22'. |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
ripe:studyEndDateExtractionRationale |
No explicit study end date found. |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA2FDF154C3D3A24A0-human-2-2 |
ripekg:study-design-evidence/RIPEA2FDF154C3D3A24A0 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA2FDF154C3D3A24A0-inspectai-2-2 |